Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.02
-0.10 (-1.10%)
May 20, 2024, 12:08 PM EDT - Market open
Avid Bioservices Market Cap
Avid Bioservices has a market cap or net worth of $573.22 million as of May 20, 2024. Its market cap has decreased by -48.04% in one year.
Market Cap
573.22M
Enterprise Value
743.13M
1-Year Change
-48.04%
Ranking
Category
Stock Price
$9.02
Market Cap Chart
Since December 1, 1998, Avid Bioservices's market cap has increased from $64.40M to $573.22M, an increase of 790.10%. That is a compound annual growth rate of 8.96%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 578.90M | -0.87% |
May 16, 2024 | 584.00M | -0.54% |
May 15, 2024 | 587.20M | 0.55% |
May 14, 2024 | 584.00M | 4.42% |
May 13, 2024 | 559.30M | 1.62% |
May 10, 2024 | 550.40M | 6.52% |
May 9, 2024 | 516.70M | -2.88% |
May 8, 2024 | 532.00M | -4.33% |
May 7, 2024 | 556.10M | 4.04% |
May 6, 2024 | 534.50M | 2.06% |
May 3, 2024 | 523.70M | 0.61% |
May 2, 2024 | 520.50M | 6.90% |
May 1, 2024 | 486.90M | 0.52% |
Apr 30, 2024 | 484.40M | 0.94% |
Apr 29, 2024 | 479.90M | 2.85% |
Apr 26, 2024 | 466.60M | 0.41% |
Apr 25, 2024 | 464.70M | 7.17% |
Apr 24, 2024 | 433.60M | 2.65% |
Apr 23, 2024 | 422.40M | 4.19% |
Apr 22, 2024 | 405.40M | 0.32% |
Apr 19, 2024 | 404.10M | -1.99% |
Apr 18, 2024 | 412.30M | -2.83% |
Apr 17, 2024 | 424.30M | -7.46% |
Apr 16, 2024 | 458.50M | 6.63% |
Apr 15, 2024 | 430.00M | 0.89% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aerovate Therapeutics | 592.59M |
PetIQ | 588.78M |
Accolade | 586.11M |
GeneDx Holdings | 585.52M |
Mind Medicine (MindMed) | 579.52M |
Allogene Therapeutics | 578.33M |
Taysha Gene Therapies | 577.89M |
enGene Holdings | 572.43M |